fetaLife Technologies S.L. has been founded in 2025 and is backed by years of research.
We are a spin-off of Hospital Sant Joan de Déu, Hospital Clínic Barcelona, and Universitat de Barcelona.
Our purpose is the research, development, manufacturing, innovation and commercialisation of medical devices and medical technology to improve the current treatment for extreme premature babies.
The research project is under development and is being promoted by Hospitals Sant Joan de Déu and Clínic in Barcelona, and boosted thanks to the support of the “la Caixa” Foundation.
Descripción del producto
fetaLife es una incubadora líquida que permitirá mantener a recién nacidos extremadamente prematuros en condiciones similares al útero materno, lo que solucionará los problemas actuales de prematuridad extrema.